154 related articles for article (PubMed ID: 10662390)
1. Pharmacoeconomics and health policy. Current applications and prospects for the future.
Greenberg PE; Arcelus A; Birnbaum HG; Cremieux PY; LeLorier J; Ouellette P; Slavin MB
Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):425-32. PubMed ID: 10662390
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomics.
Ahuja J; Gupta M; Gupta AK; Kohli K
Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomics comes of age?
Walley T; Breckenridge A
Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057
[TBL] [Abstract][Full Text] [Related]
4. Penny and pound wise: pharmacoeconomics from a governmental perspective.
van Oostenbruggen MF; Jansen RB; Mur K; Kooijman H
Pharmacoeconomics; 2005; 23(3):219-26. PubMed ID: 15836004
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
Thwaites R; Townsend RJ
Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical economy and the economic assessment of drugs in France.
le Pen C
Soc Sci Med; 1997 Aug; 45(4):635-43. PubMed ID: 9226787
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
[TBL] [Abstract][Full Text] [Related]
8. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Führlinger S
Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
[TBL] [Abstract][Full Text] [Related]
9. [Health outcomes analysis and its applications].
Carrera-Hueso FJ
Rev Med Univ Navarra; 1997; 41(4):237-44. PubMed ID: 10420964
[TBL] [Abstract][Full Text] [Related]
10. The role of pharmacoeconomics in health policy and management in Norway.
Grund J; Husbyn H
Pharmacoeconomics; 1995 Jun; 7(6):475-83. PubMed ID: 10155333
[No Abstract] [Full Text] [Related]
11. Health care reform: is the process the outcome?
Gibson E; Lyles A
Clin Ther; 2009 Sep; 31(9):2014-7. PubMed ID: 19843491
[No Abstract] [Full Text] [Related]
12. [Pharmacoeconomics - Challenges for Health Professionals].
Turčić P; Benković V; Brborović O; Valent A
Acta Med Croatica; 2016 Apr; 70(2):117-23. PubMed ID: 28722840
[TBL] [Abstract][Full Text] [Related]
13. The practical impact of pharmacoeconomics on institutional managers.
Cooke J
Pharmacoeconomics; 1994 Oct; 6(4):289-97. PubMed ID: 10147466
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomics: an emerging discipline.
Letizia C
Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866
[TBL] [Abstract][Full Text] [Related]
15. The future of pharmacoeconomics: bridging science and practice.
Drummond MF
Clin Ther; 1996; 18(5):969-78; discussion 968. PubMed ID: 8930435
[TBL] [Abstract][Full Text] [Related]
16. How to improve pharmacoeconomic data generalisability between different countries.
Li SC
Expert Opin Pharmacother; 2007 Jul; 8(10):1409-13. PubMed ID: 17661723
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoeconomics: what is it and where is it going?
McCombs JS
Am J Hypertens; 1998 Aug; 11(8 Pt 2):112S-119S; discussion 135S-137S. PubMed ID: 9717852
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomics and managed care: methodologic and policy issues.
Luce BR
Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461
[No Abstract] [Full Text] [Related]
19. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Lipsy RJ
Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
[TBL] [Abstract][Full Text] [Related]
20. Prevention, policy, and paradox: what is the value of future health?
Ganiats TG
Am J Prev Med; 1997; 13(1):12-7. PubMed ID: 9037337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
